Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

ATHN 7: Hemophilia Natural History Study

NCT03619863 ·Status: COMPLETED

PF-06741086 Long-term Treatment in Severe Hemophilia

NCT03363321 ·Status: COMPLETED ·Phase: PHASE2

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial

NCT02541942 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116 ·Status: COMPLETED ·Phase: PHASE3

Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency

NCT01312636 ·Status: COMPLETED

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

NCT03754790 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B

NCT01220141 ·Status: COMPLETED

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

NCT02083965 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A

NCT01233258 ·Status: COMPLETED ·Phase: PHASE3

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

NCT05421429 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor

NCT05487976 ·Status: UNKNOWN ·Phase: PHASE3

Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein

NCT06142552 ·Status: RECRUITING ·Phase: PHASE3

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

NCT00623480 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

NCT04370054 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever

NCT01601613 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

NCT00989196 ·Status: COMPLETED ·Phase: PHASE2

PF-06741086 Multiple Dose Study in Severe Hemophilia

NCT02974855 ·Status: COMPLETED ·Phase: PHASE2

Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies

NCT03103542 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of NGGT003 in Hemophilia A Patients

NCT06238908 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

NCT06349473 ·Status: RECRUITING ·Phase: PHASE1

A Factor IX Gene Therapy Study (FIX-GT)

NCT03369444 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

NCT01234545 ·Status: COMPLETED